Sort
16,300 grants matching “fatty liver disease”
Investigation of the Molecular Mechanisms of Lipoprotein Lipase Inhibitors
$370,960Saskia Neher · Univ Of North Carolina Chapel Hill · R01 · FY2016 · HL
The Evolution of PGD addiction in Human Pancreatic Cancer
$370,901Oliver Gene McDonald · Vanderbilt University Medical Center · R01 · FY2019 · CA
Pretreatment genotyping at APOA5 and GCKR loci and response to fenofibrate therap
$370,883Edmond Kato Kabagambe · University Of Alabama At Birmingham · R21 · FY2010 · DK
Regulation of Hepatic Metabolic Function by Parenteral Nutrition
$370,852Douglas G Burrin · Baylor College Of Medicine · R01 · FY2019 · DK
Role of Ceramide Regulated Fgf13 in AdiposeT issue Biology
$370,800Bhagirath Chaurasia · University Of Iowa · R01 · FY2024 · DK
Sphingosine kinase 2 in sexual dimorphism of hepatocellular carcinoma
$370,665Christopher D Green · Virginia Commonwealth University · R01 · FY2024 · CA
Oxidation Hypothesis--Paradoxes and Pitfalls
$370,640Emory University · R01 · FY2002 · HL
Macrophage-specific targeting of LXRs in CVD and NASH
$370,631Christopher K Glass · University Of California, San Diego · P01 · FY2020 · HL
Pivotal Role of Oxidation-specific Epitopes in CVD and NASH.
$370,629Joseph L Witztum · University Of California, San Diego · P01 · FY2020 · HL
Role of Obesity in Infection
$370,616Salomon Amar · Boston University Medical Campus · R01 · FY2011 · DE
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
$370,606Zhaoli Sun · Johns Hopkins University · U01 · FY2010 · AA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2016 · CA
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
$370,575Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2017 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2017 · CA
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
$370,575Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2021 · CA
Analytical determination of biomarkers for diagnosis of breast cancer metastatic progression
$370,575Venu Raman · Johns Hopkins University · R01 · FY2020 · CA
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
$370,575Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2020 · CA
Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma
$370,575Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2018 · CA
Targeting Shc to reduce inflammation and fibrosis in the aging liver
$370,517Natalie J Torok · Palo Alto Veterans Instit For Research · R01 · FY2019 · AG
Folate and S-adenosyimethionine in Methyl Group and One-carbon Metabolism
$370,500Conrad Wagner · Vanderbilt University · R01 · FY2009 · DK
The role of nicotinamide N-methyltransferase in glucose and lipid homeostasis
$370,485Pavlos Pissios · Beth Israel Deaconess Medical Center · R01 · FY2010 · DK
Metabolic Regulation of PEPCK Isozymes
$370,455Case Western Reserve University · R01 · FY2001 · DK
SRC-2: A Master Metabolic Regulator for Liver-Dependent Intestinal Fat Absorptio
$370,385Bert W O'Malley · Baylor College Of Medicine · P01 · FY2012 · DK
SRC-2: A Master Metabolic Regulator for Liver-Dependent Intestinal Fat Absorptio
$370,385Bert W O'Malley · Baylor College Of Medicine · P01 · FY2014 · DK
SRC-2: A Master Metabolic Regulator for Liver-Dependent Intestinal Fat Absorptio
$370,385Bert W O'Malley · Baylor College Of Medicine · P01 · FY2016 · DK